Urticaria (Hives) | Dermatology & Allergy Care in Hiroo & Ebisu, Tokyo | Yasashii Clinic
2026/4/5
Medically Reviewed by: Takafumi Suzuki, MD — Primary Care in Dermatology, Internal Medicine & Allergology; Specialist in Anesthesiology
Written by: Yasumasa Ohno — Business Development & Content Manager, Yasashii Clinic Hiroo Shirokane
Last Updated: April 2, 2026
What You'll Learn in This Article
What urticaria (hives) is — and the critical feature that distinguishes it from eczema
Why most chronic hives have no identifiable cause — and why treatment still works
The role of mast cells and histamine in every episode
When hives become a medical emergency (anaphylaxis warning signs)
How second-generation antihistamines and biologics manage chronic urticaria
Urticaria — commonly known as hives — is characterized by suddenly appearing, intensely itchy wheals (raised, red welts) that typically resolve within 24 hours without leaving marks. It affects up to 20% of people at some point in their lives. Whether you've had a single dramatic episode or have been living with recurring hives for months, effective treatment exists — and knowing when the situation is urgent can be life-saving.
Table of Contents
- What You'll Learn in This Article
- Table of Contents
- 1. What Is Urticaria (Hives)?
- 2. Symptoms — Wheals, Angioedema, and Anaphylaxis
- 3. Causes: Allergic, Non-Allergic, and Idiopathic
- 4. The Mechanism: Mast Cells and Histamine
- 5. How to Tell Hives Apart from Similar Conditions
- 6. Diagnosis: History, Examination, and Allergy Testing
- 7. Treatment — Antihistamines, Biologics, and Avoidance
- 8. How Long Does Recovery Take?
- 9. Everyday Management
- 10. Risks of Leaving Urticaria Unmanaged
- 11. Who Is at Higher Risk?
- 12. When to Seek Care — Checklist
- 13. Trigger Tracking and Relapse Prevention
- 14. Allergy & Dermatology Care at Yasashii Clinic Hiroo Shirokane
- 15. Summary
- English FAQ
1. What Is Urticaria (Hives)?
Urticaria is defined by the sudden appearance of wheals — circumscribed, erythematous, raised areas of dermal edema — associated with pruritus (itch) and, by definition, individual lesions that resolve within 24 hours without leaving permanent skin changes. Urticaria lasting less than 6 weeks is classified as acute urticaria; persistence beyond 6 weeks defines chronic urticaria.
The "resolves within 24 hours" criterion is the single most important feature separating urticaria from other inflammatory skin conditions — if a wheal is still present after 24 hours, a different diagnosis (or urticarial vasculitis) should be considered.
Common Misconceptions
"My allergy test was negative, so it can't be hives." Approximately 70% of chronic urticaria has no identifiable allergen — it is classified as chronic spontaneous (idiopathic) urticaria. IgE-based allergy testing is frequently negative, yet the condition is real and treatable.
"The welt left a mark, so it's definitely hives." True urticaria leaves no residual pigmentation. Marks left behind suggest a different diagnosis.
"OTC antihistamines are enough." For occasional acute urticaria, OTC first-generation antihistamines may provide temporary relief. For chronic or recurrent urticaria, second-generation prescription antihistamines, dose optimization, and sometimes biologics offer significantly better control.
2. Symptoms — Wheals, Angioedema, and Anaphylaxis
Wheals (Hives)
Sudden onset of circumscribed, raised, erythematous (red) or pale center plaques
Intensely pruritic (itchy)
Variable size: a few millimeters to several centimeters; may coalesce into large geographic patterns
Resolve completely within 24 hours — hallmark feature
May recur in the same or different locations
Angioedema Deep swelling of the dermis, subcutaneous tissue, or mucosa, often occurring alongside or instead of wheals:
Common sites: eyelids, lips, tongue, throat, hands, genitalia
Associated with pain or burning rather than itch
Resolves over 24–72 hours
Laryngeal (throat) angioedema is a medical emergency — airway compromise is possible
Anaphylaxis Systemic, life-threatening hypersensitivity reaction involving urticaria/angioedema plus one or more of:
Respiratory: dyspnea, stridor, wheezing
Cardiovascular: hypotension, dizziness, loss of consciousness
Gastrointestinal: nausea, vomiting, abdominal cramps
If anaphylaxis is suspected: call 119 immediately.
"About 30 minutes after eating shrimp at dinner, I noticed welts spreading across my chest and my throat felt strangely tight. I took an antihistamine and it settled — but I was scared. Could it happen again, and worse?" This scenario — urticaria with subtle throat symptoms after food exposure — warrants urgent allergy evaluation, epinephrine auto-injector (EpiPen®) prescription, and a clear anaphylaxis action plan.
3. Causes: Allergic, Non-Allergic, and Idiopathic
Allergic (IgE-mediated)
Foods: shellfish, fish, wheat, eggs, dairy, tree nuts, fruits (peach, kiwi)
Drugs: NSAIDs (aspirin, ibuprofen), penicillin and other antibiotics, contrast media
Insect venom: bees, wasps, ants
Latex (natural rubber): gloves, balloons
Animal dander
Non-allergic (direct mast cell activation)
Physical urticaria: dermographism (skin writing), cold, heat, solar, pressure, exercise-induced
Cholinergic urticaria: triggered by sweating (exercise, hot bath, emotional stress) — characteristically small wheals
Contact urticaria: immediate reaction at contact site without systemic IgE sensitization
Chronic Spontaneous (Idiopathic) Urticaria The most common form in clinical practice — approximately 70% of chronic urticaria cases have no identifiable cause. An autoimmune mechanism involving IgG autoantibodies against the high-affinity IgE receptor (FcεRI) or against IgE itself is implicated in a significant proportion.
Secondary Urticaria Associated with: viral infections (common cold, COVID-19), parasitic infection, thyroid disease (Hashimoto's), systemic lupus erythematosus, lymphoma.
4. The Mechanism: Mast Cells and Histamine
The final common pathway of urticaria, regardless of trigger, is mast cell degranulation and histamine release.
Mast cell activation: Via IgE crosslinking (allergic), direct receptor stimulation (physical, drug), or autoantibody-mediated activation (chronic spontaneous urticaria)
Mediator release: Histamine, prostaglandins, leukotrienes, and tryptase are released from mast cell granules
Vascular response: Histamine binds H1 receptors on dermal blood vessels → vasodilation (redness) + increased vascular permeability (plasma leakage into dermis → wheal)
Itch signal: Histamine activates H1 receptors on sensory C-fibers → intense pruritus
Why wheals resolve: Released histamine is rapidly metabolized. If the stimulus for mast cell activation is removed (allergen cleared, physical trigger ends), new degranulation stops and wheals resolve.
Why antihistamines work: Second-generation H1 antihistamines competitively block histamine at the H1 receptor, preventing vasodilation, plasma leakage, and itch. They do not prevent mast cell degranulation — hence why trigger avoidance remains important.
5. How to Tell Hives Apart from Similar Conditions
Condition | Resolution | Residual mark | Key distinguishing feature |
|---|---|---|---|
Urticaria | < 24 hours | None | Migratory, resolves completely |
Atopic Dermatitis | Chronic | Pigmentation, lichenification | Atopic background; chronic, not episodic |
Contact Dermatitis | Days–weeks | Sometimes | Confined to contact site; slower onset |
Erythema Multiforme | 1–3 weeks | Sometimes | Target lesions; fixed location; post-infection |
Urticarial Vasculitis | > 24 hours | Pigmentation | Burns rather than itches; biopsy confirms |
Insect bite | Days | Sometimes | Single site; sting mark visible |
Key clinical test: Mark an active wheal with a pen — if it is still present 24 hours later, urticaria is an unlikely diagnosis and vasculitis workup should be considered.
6. Diagnosis: History, Examination, and Allergy Testing
Physical Examination Assessment of wheal morphology, distribution, dermographism, angioedema presence. For physical urticaria: ice cube test (cold urticaria), exercise test, pressure test as appropriate.
Medical History (the cornerstone of urticaria diagnosis)
Onset, frequency, duration of individual lesions
Timing relative to meals, medications, exercise, bathing, stress
Full medication list — including NSAIDs, ACE inhibitors (can cause angioedema), OTC supplements
Dietary diary — particularly for acute episodes
Past medical history: thyroid disease, autoimmune conditions, recurrent infections
Anaphylaxis history — critical safety question
Laboratory Tests
Complete blood count, CRP: screen for infection, eosinophilia
Thyroid function, anti-thyroid antibodies: thyroid autoimmunity is associated with chronic spontaneous urticaria
Antinuclear antibody (ANA): screen for systemic autoimmune disease
Total IgE and specific IgE panel: guided by clinical suspicion — positive results must be interpreted in clinical context
Skin prick testing: for specific allergen confirmation
Physical urticaria tests: dermographometer, ice cube test, exercise challenge
Your First Visit — Step by Step
Book via LINE (24/7): https://line.me/R/ti/p/@744yxkjg
or call: +81-3-6456-4990
↓
Complete intake form — include details of recent meals, medications, timeline
↓
Consultation — approx. 25–35 minutes
↓
Allergy testing (blood draw) if indicated
↓
Prescription + urticaria diary guidance / PaymentBring: Insurance card, current medications list, any dietary or symptom diary you've kept.
7. Treatment — Antihistamines, Biologics, and Avoidance
Trigger Avoidance — foundational For identified triggers (specific foods, NSAIDs, physical factors): strict avoidance is the priority.
Second-Generation H1 Antihistamines — Insurance covered; first-line treatment Non-sedating antihistamines (bilastine, fexofenadine, cetirizine, olopatadine, loratadine) taken daily — not only when symptomatic. Key principles:
Take every day for chronic urticaria, even on symptom-free days
Standard dose initially; if insufficient, dose can be increased up to 4× standard dose (guideline-supported)
Different agents can be tried if one is ineffective
H2 Antihistamines (adjunctive) Adding famotidine to an H1 antihistamine may provide additional benefit through complementary receptor blockade.
Omalizumab (Xolair®) — Insurance covered for chronic spontaneous urticaria refractory to antihistamines A monoclonal antibody targeting IgE — reduces mast cell sensitivity to IgE-mediated activation. Administered as a subcutaneous injection every 4 weeks. Clinical trials demonstrate rapid, high-efficacy response in a significant proportion of patients with treatment-refractory chronic urticaria. Remarkable efficacy even in IgE-negative, idiopathic urticaria.
Short-course oral corticosteroids — Insurance covered; acute severe cases only For severe acute urticaria or angioedema not responding to antihistamines. Not appropriate for long-term chronic urticaria management.
Epinephrine Auto-injector (EpiPen®) — Prescription Prescribed for patients with a history of anaphylaxis or high anaphylaxis risk. We provide injection technique training at the time of prescription.
8. How Long Does Recovery Take?
Acute urticaria (identified trigger): Resolution expected within 1–2 weeks of trigger avoidance + antihistamine treatment
Chronic spontaneous urticaria:
50% achieve spontaneous remission within 1 year;20% have persistent disease at 5 years. Ongoing antihistamine management is required throughout.Omalizumab responders: Meaningful symptom reduction typically within 4–8 weeks; some patients achieve complete remission
The goal is not immediate cure but sustained symptom control with minimal medication burden — progressively stepping down treatment as disease activity decreases.
9. Everyday Management
During a flare
Cool (not cold) compresses on affected areas reduce itch temporarily
Avoid scratching — scratch stimulation triggers further mast cell degranulation and spreads wheals
Avoid hot baths, alcohol, and vigorous exercise during active episodes — all promote histamine release
Take prescribed antihistamines consistently
Daily habits for chronic urticaria
Take antihistamines at the same time each day — consistency matters more than timing relative to symptoms
Keep a urticaria diary: date/time, symptom intensity (1–10 scale), food eaten, medications taken, activity, stress level
Avoid NSAIDs for pain/fever — use acetaminophen instead
Moderate alcohol intake
Manage stress: walks around Arisugawa-no-miya Memorial Park, regular sleep, structured relaxation
10. Risks of Leaving Urticaria Unmanaged
Anaphylaxis risk: Patients with food-triggered or drug-triggered urticaria may progress to anaphylaxis on subsequent exposure. Not every episode of urticaria warns you — the next one may be systemic. Epinephrine auto-injector access and an action plan are essential.
Missed underlying diagnosis: Urticaria as a presenting symptom of thyroid disease, autoimmune disease, or occult infection is frequently missed when patients self-treat with OTC antihistamines without investigation.
Urticarial vasculitis: Misidentified as ordinary urticaria, vasculitis can cause renal, joint, and organ involvement if untreated.
Chronic QOL impact: Chronic itching causes sleep deprivation, anxiety, depression, and significant impairment in work and social functioning. The psychological burden of chronic urticaria rivals that of psoriasis and eczema in severity studies — it deserves medical attention proportionate to that burden.
11. Who Is at Higher Risk?
People with food allergies (particularly shellfish, tree nuts, wheat): anaphylaxis risk assessment and epinephrine prescription are important
Women aged 20–40: chronic spontaneous urticaria is more common in women, possibly related to autoimmune predisposition
People taking NSAIDs regularly: NSAIDs are among the most common drug triggers of urticaria; switching to acetaminophen is often beneficial
Patients with autoimmune thyroid disease: association with chronic spontaneous urticaria is well-established
Expats and international residents in Hiroo and Shirokane: unfamiliar Japanese foods (fermented products, specific seafood, certain food additives) and environmental changes can trigger new urticaria; English-language allergy care is available at our clinic
12. When to Seek Care — Checklist
Emergency — call 119 immediately:
Throat tightness, voice change, difficulty breathing
Dizziness, low blood pressure, or loss of consciousness with hives
Rapid generalized spread of hives with any systemic symptom
Urgent — same day or next day:
☑ Widespread rapidly spreading hives with lip/eyelid/tongue swelling
☑ History of anaphylaxis with any food or drug
☑ Hives occurring with every exposure to a specific food or drug
Routine — within a few days:
☑ Hives occurring more than twice per week for more than 6 weeks
☑ OTC antihistamines are not controlling symptoms adequately
☑ Individual wheals persist longer than 24 hours or leave marks
☑ Children with recurrent hives of unknown cause
13. Trigger Tracking and Relapse Prevention
Urticaria Diary — What to Record
Field | What to include |
|---|---|
Date/Time | Time of onset relative to meals/activities |
Symptom severity | Scale 1–10; body areas involved |
Food and drink | Everything consumed in the 24 hours before onset |
Medications | All prescription, OTC, and supplements |
Activities | Exercise, bathing, sun exposure, emotional stress |
For women | Menstrual cycle day |
Sharing this diary at your follow-up appointment enables us to identify patterns that a single consultation cannot reveal.
Avoiding known triggers in Tokyo
Check ingredient labels carefully when shopping at supermarkets in Hiroo and Ebisu — shellfish, wheat, and nut derivatives are present in many processed foods
When dining at restaurants along Hiroo Promenade or near Daikanyama, communicate allergens clearly to staff; menus may not list all ingredients
Replace NSAIDs with acetaminophen for routine pain management
Stay cool during the summer months when walking near Shizen-kyoiku-en or along Platinum-dori — heat-triggered and cholinergic urticaria flare in warm weather
14. Allergy & Dermatology Care at Yasashii Clinic Hiroo Shirokane
English-Friendly, Integrated Allergy and Dermatology Care
We regularly see patients from the international community in Hiroo, Minami-Azabu, Shirokane, and Ebisu for urticaria evaluation and management. English consultations are available. We are accustomed to taking detailed dietary histories, reviewing ingredient lists, and explaining allergy test results in a way that is clear and actionable — in English.
We accept Japanese national health insurance and self-pay. For international insurance plans, we provide documentation for reimbursement claims.
Why Our Clinic Is Particularly Well-Suited for Urticaria
Urticaria sits at the intersection of dermatology, allergology, and internal medicine — all three of which are practiced at our clinic. Dr. Suzuki's background in critical care and internal medicine means we are alert to the systemic presentations of urticaria (anaphylaxis, vasculitis, systemic autoimmune disease) and can manage these dimensions alongside the dermatological aspect of care.
"Chronic hives is not 'just a skin problem.' The impact on sleep, work, and mental health is profound — and there are effective treatment options that many patients are not yet aware of."
For cases requiring omalizumab management monitoring, complex immunological workup, or anaphylaxis risk assessment beyond our scope, we maintain referral pathways to Tokyo Metropolitan Hiroo Hospital, Japanese Red Cross Medical Center, Kitasato University Kitasato Institute Hospital, and The Institute of Medical Science Hospital (University of Tokyo).
Access & Hours
5 min walk from Hiroo Station (Tokyo Metro Hibiya Line, Exit 2)
10 min walk from Ebisu Station (JR / Tokyo Metro)
13 min from Shirokanedai and Shirokane-Takanawa Stations
Parking available
Opening Hours: Monday: 16:00–20:00 | Wednesday & Thursday: 10:00–14:00 / 16:00–20:00 Saturday & Sunday: 10:00–18:00 | Public Holidays: 10:00–14:00 Closed: Tuesday, Friday Please check the official website or call for the latest schedule.
Related diseases
Other related
15. Summary
Urticaria is defined by wheals that resolve within 24 hours without leaving marks — this single feature differentiates it from almost all other inflammatory skin conditions
Most chronic urticaria (>6 weeks) is idiopathic — negative allergy tests do not mean the condition isn't real or treatable
Daily second-generation antihistamines are the backbone of treatment; omalizumab (Xolair®) is available for antihistamine-refractory chronic urticaria
Throat swelling, breathing difficulty, or systemic symptoms with hives = potential anaphylaxis = 119 immediately
Recurring hives warrant a systematic clinical evaluation, not just OTC antihistamine use
English FAQ
Q1. What causes urticaria (hives)? Causes include allergic reactions (food, drugs, insect venom, latex), physical triggers (cold, heat, pressure, exercise), infections, and autoimmune mechanisms. About 70% of chronic urticaria has no identifiable cause (chronic spontaneous urticaria).
Q2. Is urticaria contagious? No. Urticaria is not an infection and cannot be transmitted to others. It is an immune-mediated skin reaction. If urticaria follows a viral illness, the virus may have been contagious — but the hives themselves are not.
Q3. How long does urticaria treatment take? Acute urticaria with an identified trigger resolves within 1–2 weeks of trigger removal and antihistamine treatment. Chronic urticaria requires ongoing daily antihistamine management; about 50% of patients achieve spontaneous remission within one year.
Q4. Are OTC antihistamines enough? For occasional mild acute hives: possibly. For chronic, recurrent, or severe urticaria: prescription second-generation antihistamines at optimized doses provide significantly better control. If hives are recurring, a medical evaluation to rule out anaphylaxis risk and systemic causes is important.
Q5. When is it an emergency? Call 119 immediately if urticaria is accompanied by throat tightness, voice change, difficulty breathing, dizziness, low blood pressure, or loss of consciousness.
Q6. What is the difference between urticaria and angioedema? Urticaria involves wheals in the superficial dermis. Angioedema is deeper swelling in the subcutaneous tissue, typically affecting the face (lips, eyelids, tongue) and sometimes the throat. They frequently occur together. Throat angioedema is a medical emergency.
Q7. What is omalizumab (Xolair®) and who should consider it? Omalizumab is a biologic medication (anti-IgE antibody) that reduces mast cell sensitivity. It is approved in Japan for chronic spontaneous urticaria that has not responded adequately to antihistamines, even at increased doses. It is administered by subcutaneous injection every 4 weeks and is covered by Japanese health insurance for qualifying patients.
Q8. Do you see foreign patients? Is English available? Yes — we regularly treat urticaria in expats and foreign residents in Hiroo, Minami-Azabu, Shirokane, and Ebisu. English is available.
Q9. Is urticaria treatment covered by Japanese health insurance? Yes. Consultations, antihistamine prescriptions, and blood allergy testing are covered. Omalizumab is covered for chronic spontaneous urticaria refractory to antihistamines (with prior authorization). EpiPen® (epinephrine auto-injector) is covered by prescription for patients at risk of anaphylaxis.
Q10. Can I have an online consultation for urticaria? Yes — follow-up consultations and chronic urticaria monitoring are available online. For first visits, anaphylaxis risk assessment, or allergy testing, an in-person visit is recommended.
Author:Name: Yasumasa Ohno
Role: Business Development & Content Manager, Yasashii Clinic Hiroo Shirokane
Medical Reviewer:
Name: Takafumi Suzuki, MD
Credentials: Specialist in Anesthesiology (Japan Board of Anesthesiology)
Affiliations:
- Japanese Society of Anesthesiologists (JSA)
- Japanese Society of Internal Medicine (JSIM)
- Japanese Society of Intensive Care Medicine (JSICM)
- Japanese Association for Cardiovascular Anesthesia (JACA)
Clinical Background: Critical care medicine, perioperative management, pain medicine; primary care in internal medicine, dermatology, allergology, and sleep medicine (OSA)
Operating Organization:
Name (Japanese): やさしいクリニック 広尾 白金
Name (English): Yasashii Clinic Hiroo Shirokane
Address: O-KA Building 3F, 2-31-3 Ebisu, Shibuya-ku, Tokyo 150-0013, Japan
Tel: +81-3-6456-4990
URL: https://yasashii-clinic.jp
Booking: https://line.me/R/ti/p/@744yxkjg (LINE, 24/7)
Specialties: Internal Medicine / Dermatology / Allergology / Pain Clinic
Opening Hours:
Monday : 16:00–20:00
Tuesday : Closed
Wednesday : 10:00–14:00 / 16:00–20:00 (2nd & 4th Wed: morning only)
Thursday : 10:00–14:00 / 16:00–20:00
Friday : Closed
Saturday : 10:00–18:00
Sunday : 10:00–18:00
Public Holidays: 10:00–14:00
* Hours subject to change. Please check the official website for the latest schedule.
Access:
5 min walk from Hiroo Station (Tokyo Metro Hibiya Line, Exit 2)
10 min walk from Ebisu Station (JR / Tokyo Metro)
13 min walk from Shirokane-Takanawa / Shirokanedai Station
Languages: Japanese (primary), English available
Online Consultation: Available
Payment: Cash / Credit cards accepted
Last Updated: 2026-04-02
Medical Disclaimer:
This article is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. The information provided reflects current medical knowledge at the time of writing. Individual symptoms and conditions vary; please consult a qualified physician for personal medical advice. If you are experiencing an emergency, contact emergency services immediately. This content has been medically reviewed by a licensed physician.
参考文献
- Zuberbier T, et al. "The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria." Allergy. 2022; 77(3): 734–766.
- 日本皮膚科学会. 「蕁麻疹診療ガイドライン2023」. 日本皮膚科学会雑誌. 2023. https://www.dermatol.or.jp/modules/guideline/
- Maurer M, et al. "Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria." New England Journal of Medicine. 2013; 368(10): 924–935.
- Kaplan AP. "Therapy of chronic urticaria: a simple, modern approach." Annals of Allergy, Asthma & Immunology. 2014; 112(5): 419–425.
- Bernstein JA, et al. "The diagnosis and management of acute and chronic urticaria: 2014 update." Journal of Allergy and Clinical Immunology. 2014; 133(5): 1270–1277.
- Magerl M, et al. "The definition, diagnostic testing, and management of chronic inducible urticarias." Allergy. 2016; 71(6): 780–802.
- Simons FER, et al. "2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines." World Allergy Organization Journal. 2015; 8(1): 32.
- Vonakis BM, Saini SS. "New concepts in chronic urticaria." Current Opinion in Immunology. 2008; 20(6): 709–716.
- Zuberbier T, et al. "EAACI/GA²LEN/EDF/WAO guideline: management of urticaria." Allergy. 2009; 64(10): 1427–1443.
- 厚生労働省. 「アレルギー疾患対策に関する情報」. https://www.mhlw.go.jp/
- Kolkhir P, et al. "Comorbidity and pathophysiology of chronic spontaneous urticaria." Allergy. 2017; 72(3): 313–333.
- Weller K, et al. "Development and validation of the Urticaria Control Test." Allergy. 2014; 69(10): 1393–1400.
⚠️ 参考文献検証のお願い:本参考文献リストはAIが生成しており、
URLや掲載巻号が実際の論文情報と異なる可能性があります。
公開前に以下の方法でご確認ください:
・PubMed:https://pubmed.ncbi.nlm.nih.gov/
・日本皮膚科学会ガイドライン:https://www.dermatol.or.jp/modules/guideline/
・厚生労働省:https://www.mhlw.go.jp/
皮膚科の診療内容一覧
やさしいクリニック 広尾 白金
©︎2026 やさしいクリニック 広尾 白金

